| HA | screening and diagnostic method b-out d-out qh |
| SN | This section contains specific methods, instruments, tests, etc., used in screening, identification, and diagnosis. For descriptors dealing with the process and other aspects of screening,
identification, and diagnosis, see *+JG26 identification and screening* qh ah. These descriptors refer to
the methods themselves as well as the results or scores obtained using them.
Screening is the preliminary identification of a disease or defect by means of tests, examinations, or other procedures that can be applied rapidly. Diagnosis is the definitive determination of the nature or identity of a disease, typically based on an analysis of signs and symptoms, the patient's medical history, and often on the results of laboratory tests. Screening and diagnosis often employ similar methods. This section first gives medical diagnostic methods and techniques that are defined according to the physical, chemical, or biological methods used. It next gives diagnostic methods defined according to the specific body systems, organs, or parts to which they are applied. It concludes with psychological tests. | |
| ST | diagnostic test | |
| screening and diagnostic instruments and scales | ||
| NT | +HB AODU screening, identification, and diagnostic method qh ah | |
| +HCe medical screening and diagnostic method qh ah | ||
| +HHe psychosocial screening and diagnostic method qh ah | ||
| RT | GA6.4.2e diagnostic criteria qh ah | |
| +HF26e biological markers qh ah | ||
| +J prevention, treatment, and maintenance. health care qh ah | ||
| +JC2.4e secondary prevention qh ah | ||
| +JG26e identification and screening qh ah | ||
| +JJe intervention (persuasion to treatment) qh ah | ||
| +JL treatment and patient care qh ah | ||
| +JN patient assessment and diagnosis qh ah | ||
| +JN4e diagnosis qh ah | ||
| +RM22.8e specificity and sensitivity of measurement qh ah |
| HA2 | general description of diagnostic methods qh |
| HN | Introduced 2000. |
| HA2.2 | screening/diagnostic method for potential/actual disorder qh |
| HN | Introduced 1995. |
| HA2.2.2 | . screening and diagnostic method for potential disorder qh |
| HN | Introduced 1995. | |
| NT | HB4.2e screening and diagnostic method for potential AODD qh ah | |
| RT | +JA6 risk and protective factors qh ah |
| HA2.2.4 | . screening and diagnostic method for actual disorder qh |
| HN | Introduced 1995. | |
| NT | +HB4.4e screening and diagnostic method for actual AODD qh ah |
| HA2.4e | diagnostic algorithm qh |
| HN | ETOH descriptor 2000. | |
| ST | diagnostic tree |
| HA2.4.2e | . computer-aided diagnosis qh |
| HA2.6 | invasive vs noninvasive procedure qh |
| HN | Introduced 2000. | |
| SN | These descriptors are used for both diagnostic and treatment methods or procedures. |
| HA2.6.2 | . invasive procedure qh |
| HN | Introduced 2000. | |
| SN | A procedure requiring insertion of an instrument or device into the body through the skin or a body orifice. | |
| NT | HD10 surgical diagnosis qh ah | |
| +HE4e endoscopy qh ah | ||
| +HVe operative surgery qh ah |
| HA2.6.4 | . noninvasive procedure qh |
| HN | Introduced 2000. |
| HB | AODU screening, identification, and diagnostic method d-out qh |
| SN | Specific methods, instruments, tests, etc., used in screening, identification, and diagnosis of individuals for AOD use, abuse, or disorder in medical or nonmedical contexts. Do not confuse with
*+EE18 drug evaluation* qh ah.
This section classifies methods by their purpose, whether they are intended to detect and substantiate AOD use or potential or actual AOD use disorder. Combine as needed with a specific method given in the remainder of this section. | |
| ST | drug testing methods | |
| drug usage screening methods | ||
| drug usage testing methods | ||
| BT | +HA screening and diagnostic method qh ah | |
| RT | +EE18e drug evaluation qh ah | |
| +J prevention, treatment, and maintenance. health care qh ah | ||
| JA2.2.6e treatment outcome in HSR qh ah | ||
| +JBe prevention qh ah | ||
| +JC2.4e secondary prevention qh ah | ||
| +JG26.2.4.2e identification and screening for AOD use qh ah | ||
| +RCe research and evaluation method qh ah |
| HB2e | screening and diagnostic method for AOD use qh |
| NT | +OBe AOD use detection technology qh ah | |
| RT | HF2e urinalysis qh ah | |
| +HF4 breath analysis qh ah | ||
| HF6e saliva analysis qh ah | ||
| HF8e sweat analysis qh ah | ||
| HF10e hair analysis qh ah | ||
| HF12e tears analysis qh ah | ||
| +JG26.2.4.2e identification and screening for AOD use qh ah | ||
| JG26.2.4.2.2 identification and screening for acute AOD use qh ah | ||
| +MN20.6 AOD testing laws qh ah | ||
| MO6.8.2e evidentiary proof of AODU qh ah | ||
| OZ2.2e screening for AODU in athletes qh ah |
| HB2.4e | . AOD use screening method qh |
| SN | Methods used primarily for preliminary screening for AOD use. |
| HB2.6e | . AOD use testing method qh |
| SN | Methods for a definitive determination of AOD use and its level. | |
| ST | AOD use identification method |
| HB2.8e | . BAC qh |
| SN | Use this descriptor when a document discusses both the level of BAC and methods for obtaining it or when the document discusses the topic very generally. | |
| ST | BAL | |
| blood alcohol concentration | ||
| blood alcohol level | ||
| BT | +BBe alcohol in any form qh ah | |
| +EE12.6.2.4 blood drug concentration qh ah | ||
| +HF18e blood chemistry qh ah | ||
| RT | +MN32.2 drinking-and-driving laws qh ah | |
| +MN32.2.2.4e illegal per se laws qh ah |
| HB2.8.2e | . . BAC level qh |
| HN | ETOH descriptor 2000. | |
| SN | Use when document discusses the level of blood alcohol concentration. | |
| ST | blood alcohol concentration level | |
| NT | MN32.2.2.4.2e legal BAC limit qh ah |
| HB2.8.4e | . . BAC method qh |
| SN | Use when document discusses the method(s) for obtaining the blood alcohol concentration. | |
| ST | BAC determination | |
| blood alcohol concentration measurement | ||
| blood alcohol concentration method | ||
| blood alcohol level measurement | ||
| BT | +BBe alcohol in any form qh ah | |
| RT | MO6.8.2e evidentiary proof of AODU qh ah |
| HB2.8.4.2 | . . . Widmark method qh |
| HB4e | screening and diagnostic method for AODD qh |
| HB4.2e | . screening and diagnostic method for potential AODD qh |
| ST | AODD risk identification | |
| BT | +HA2.2.2 screening and diagnostic method for potential disorder qh ah | |
| RT | +HB4.6e AODR markers qh ah | |
| +JA6 risk and protective factors qh ah | ||
| +JA8.2e risk assessment qh ah | ||
| +JG26.2.2e health risk assessment qh ah |
| HB4.4e | . screening and diagnostic method for actual AODD qh |
| HN | ETOH descriptor 2000. | |
| SN | Physically based screening and diagnostic methods for actual AODD. | |
| BT | +HA2.2.4 screening and diagnostic method for actual disorder qh ah | |
| RT | +HB4.6e AODR markers qh ah | |
| JG26.2.4.2.4e identification and screening for AODD qh ah |
| HB4.4.2 | . . physical AODD identification/diagnosis qh |
| RT | MO6.8.2e evidentiary proof of AODU qh ah |
| HB4.4.4 | . . toxicology screening qh |
| SN | Toxicology screening is a battery of tests, rather than a mass screening method, used to identify frequent intoxications. |
| HB4.6e | . AODR markers qh |
| HN | Introduced 2000. | |
| SN | Any characteristics that indicate potential or actual alcohol or other drug use disorders. Combine with *HB4.2 screening and diagnostic method for potential AODD* qh ah or *+HB4.4 screening and diagnostic method for actual AODD* qh ah as appropriate. |
| HB4.6.2e | . . AODR biological markers qh |
| HN | Changed descriptor 2000; through 1999 use "biological marker of potential AODD". | |
| NT | HF16.6.8e mean corpuscular volume qh ah | |
| BT | +HF26e biological markers qh ah | |
| RT | +JA6.12.6 biological risk and protective factors qh ah |
| HB4.6.2.2e | . . . AODR biochemical markers qh |
| HN | Introduced 2000. | |
| NT | YC16.2.6e gamma glutamyl transferase qh ah | |
| YC16.4.2.2 mitochondrial aspartate aminotransferase qh ah | ||
| +ZK2.4.2.2.4e phosphatidylethanol qh ah | ||
| ZO6.4.10.8.4.2.2e carbohydrate-deficient transferrin qh ah |
| HB4.6.2.4e | . . . AODR genetic markers qh |
| HN | Changed descriptor 2000; through 1999 use "genetic marker of potential AODD". | |
| ST | AODR phenotypes | |
| NT | HB4.6.2.8.4 alcohol-related genetic markers qh ah | |
| BT | +HF26.4e genetic markers qh ah | |
| RT | AK4.2.2 genetic AODC qh ah | |
| JA6.12.6.6 genetic risk and protective factors qh ah |
| HB4.6.2.6 | . . . AODR clinical markers qh |
| HN | Introduced 2000. | |
| BT | +HF26.6 clinical markers qh ah |
| HB4.6.2.8 | . . . alcohol-related biological markers qh |
| ST | marker of alcohol-induced injury | |
| NT | HF16.6.8e mean corpuscular volume qh ah | |
| HG22.8.6.2e P3 amplitude qh ah | ||
| BT | +BBe alcohol in any form qh ah |
| HB4.6.2.8.2 | . . . . alcohol-related biochemical markers qh |
| HN | Introduced 2000. | |
| NT | YC10.4e adenylyl cyclase qh ah | |
| YC14.8.2e monoamine oxidase qh ah | ||
| YC16.2.6e gamma glutamyl transferase qh ah | ||
| +YC16.4.2e aspartate aminotransferase qh ah | ||
| YC16.4.4e alanine aminotransferase qh ah | ||
| ZO6.4.4.2.2e glial fibrillary acidic protein qh ah | ||
| ZO6.4.10.8.4.2.2e carbohydrate-deficient transferrin qh ah | ||
| ZT6.10.2.2e 5-hydroxytryptophol qh ah |
| HB4.6.2.8.4 | . . . . alcohol-related genetic markers qh |
| ST | alcohol-related phenotypes | |
| BT | +HB4.6.2.4e AODR genetic markers qh ah | |
| RT | GR2.2e alcohol flush reaction qh ah | |
| GW8.4.6.4 color blindness qh ah | ||
| +HG22.8.6e evoked potential qh ah | ||
| +YC14.2.2.2e ADH isoenzymes qh ah | ||
| +YC14.4.2.2e aldehyde dehydrogenase isoenzyme qh ah |
| HB4.6.4e | . . AODR behavioral markers qh |
| HN | Introduced 2000. | |
| BT | +HF28 behavioral markers qh ah | |
| RT | +JA6.16 behavioral risk and protective factors qh ah |
| HB4.6.6e | . . AODR sociocultural markers qh |
| HN | Introduced 2000. | |
| BT | +HF30 sociocultural markers qh ah | |
| RT | JA6.14.6.8.8 sociocultural risk and protective factors qh ah |
| HB6e | psychosocial AODU identification and diagnostic method qh |
| RT | +JN2e patient assessment qh ah | |
| MO6.8.2e evidentiary proof of AODU qh ah |
| HB6.2e | . patient AODU history qh |
| ST | client AODU history | |
| individual AODU history | ||
| BT | +JN2.4e patient history qh ah | |
| +JN2.4.2e medical history qh ah | ||
| RT | +PN4.2e history of AOD use qh ah | |
| RP2.2e study subject AODU history qh ah |
| HB6.4e | . family AODU history qh |
| SN | Refers broadly to a family's history of alcohol and other drug use, the AOD use habits of a family, including social use, frequency, amount, abuse, and dependence. For example, it is used to describe documents discussing a patient's family's history of using alcohol or other drugs. It is a broader term than *+GC18.10 familial alcoholism* qh ah, which is a disorder classification referring to alcohol dependence (alcoholism) in the family. | |
| NT | +GC18.10e familial alcoholism qh ah | |
| BT | +LG2 family and AOD qh ah | |
| RT | JN2.4.6e patient family history qh ah |
| HB6.6 | . personal experience as AODD indicator qh |
| HB6.8 | . personal problem as AODD indicator qh |
| RT | +AN4e interpersonal AODR problems qh ah | |
| +GA2e state of health qh ah | ||
| +LC interpersonal interaction and group dynamics qh ah | ||
| +LG18e family relations qh ah | ||
| +LKe life event qh ah | ||
| +LK2.34 legal problem as a life event qh ah | ||
| +LK6 financial change or event qh ah | ||
| +MU12.14e employee absenteeism qh ah | ||
| +MU14.8 change in job status qh ah |
| HB6.10e | . specific AODU measurement and test qh |
| ST | instruments for addiction assessment | |
| BT | +RP12.2e specific data collection instrument qh ah |
| HB6.10.48e | . . adolescent AOD use test qh |
| HN | Introduced 2000. | |
| SN | Screening and diagnostic tests targeting adolescents and children for AOD use or AODR problems. |
| HB6.10.50e | . . alcohol use test qh |
| ST | alcohol dependence tests |
| HB6.10.50.92e | . . . alcohol quantity-frequency methods qh |
| HN | Introduced 2000. | |
| ST | QF methods |
| HB6.10.50.94e | . . . adolescent alcohol use test qh |
| HN | Introduced 2000. | |
| SN | Screening and diagnostic instruments targeting adolescents and children for alcohol use and alcohol related problems. |
| HCe | medical screening and diagnostic method d-out qh |
| NT | +HD general diagnostic method qh ah | |
| +HE endoscopy, imaging, and graphical representation qh ah | ||
| +HFe laboratory test qh ah | ||
| +HG system-specific diagnostic method qh ah | ||
| BT | +EZ biological laboratory methods qh ah | |
| +HA screening and diagnostic method qh ah | ||
| RT | +RCe research and evaluation method qh ah |
| HD | general diagnostic method d-out qh |
| BT | +HCe medical screening and diagnostic method qh ah | |
| RT | +EA10e biological structure qh ah |
| HD2 | . physical examination qh |
| SN | Also index the appropriate *+EH body system or organ function* qh ah and/or the appropriate *+X body part* qh ah. | |
| NT | HG22.2e neurologic examination qh ah | |
| RT | EA12e body temperature qh ah | |
| +GFe symptom qh ah | ||
| +HE4e endoscopy qh ah | ||
| +HG6 cardiovascular diagnosis qh ah | ||
| JN2.6 patient state qh ah |
| HD2.4 | . . body measurement qh |
| NT | EA10.6e body height qh ah | |
| +EA10.8e body weight qh ah |
| HD2.4.2e | . . . morphometric analysis qh |
| HN | Introduced 2000. | |
| RT | +GJ2.16e chemical intrauterine disorder qh ah | |
| +GJ4.2.4e congenital morphologic anomaly qh ah |
| HD4e | . physical performance test qh |
| HN | Introduced 1995. Prior to this use performance test. | |
| RT | HH18e psychological performance test qh ah |
| HD6e | . patient monitoring qh |
| ST | physiologic monitoring | |
| RT | +HG2.12e fetal monitoring qh ah |
| HD8 | . dietary assessment qh |
| HN | Introduced 2000. | |
| ST | food assessment | |
| RT | EA24.2e diet qh ah | |
| +HS2 nutritional therapy qh ah |
| HD10 | . surgical diagnosis qh |
| BT | +HA2.6.2 invasive procedure qh ah | |
| RT | +HD12.2e biopsy qh ah | |
| +HVe operative surgery qh ah |
| HD12e | . pathology report qh |
| HD12.2e | . . biopsy qh |
| RT | HD10 surgical diagnosis qh ah | |
| +HVe operative surgery qh ah |
| HD12.2.2 | . . . needle biopsy qh |
| RT | +HV6.14 surgical puncture qh ah |
| HD12.4e | . . autopsy qh |
| ST | postmortem examination | |
| BT | +JN4.8e postmortem diagnosis qh ah | |
| +RE10e postmortem study qh ah | ||
| RT | JU8.2.4.16e medical examiner report qh ah |
| HD14e | . radioisotope diagnosis qh |
| ST | radionuclide diagnosis | |
| NT | +HE6.4e radionuclide imaging qh ah | |
| RT | +CQ6 radiation measurement qh ah | |
| HF20.18.8e radioimmunoassay qh ah |
| HE | endoscopy, imaging, and graphical representation d-out qh |
| BT | +HCe medical screening and diagnostic method qh ah |
| HE2e | . anthropometry qh |
| HN | Introduced 2000. | |
| ST | anthropometric measurement |
| HE2.2e | . . computer-based morphometric analysis qh |
| HN | Introduced 2000. | |
| SN | Useful in the diagnosis of fetal alcohol syndrome | |
| ST | computer-assisted morphometric analysis | |
| BT | +HG4 musculoskeletal diagnosis qh ah | |
| RT | +GJ2.16.2.4.6e fetal alcohol syndrome qh ah |
| HE4e | . endoscopy qh |
| NT | HG2.6 amnioscopy qh ah | |
| HG2.10 fetoscopy qh ah | ||
| BT | +HA2.6.2 invasive procedure qh ah | |
| RT | +HD2 physical examination qh ah | |
| +HG8 respiratory system diagnosis qh ah | ||
| +HG10 mouth, larynx, or vocal organ test qh ah | ||
| +HG12 digestive system diagnosis qh ah |
| HE4.6 | . . panendoscopy qh |
| HE6e | . diagnostic imaging qh |
| NT | +HG22.4e neuroimaging qh ah | |
| BT | +CR imaging technique qh ah |
| HE6.2e | . . radiography qh |
| SN | Producing images of body structures through radiation; the images can be captured on film, on a fluorescent screen, or in a computer file. | |
| ST | roentgenography | |
| NT | +HG22.4.2 neuroradiography qh ah | |
| RT | +HG6 cardiovascular diagnosis qh ah | |
| +HG8 respiratory system diagnosis qh ah | ||
| +HG12 digestive system diagnosis qh ah | ||
| +HG14 urologic diagnosis qh ah |
| HE6.2.2 | . . . fluoroscopy qh |
| SN | Producing an x-ray image on a fluorescent screen. In photofluoroscopy, this image is photographed. |
| HE6.2.4 | . . . film radiography qh |
| SN | Producing an x-ray image on a film. |
| HE6.2.4.2 | . . . . x-ray film tomography qh |
| SN | A special radiologic technique to demonstrate on film the details of structures in a predetermined plane of tissue, with blurring of the details in other planes. | |
| ST | body section radiography |
| HE6.2.4.4 | . . . . scanography qh |
| SN | A radiographic technique in which a narrow slit is used beneath the x-ray tube in such a manner that only a line or sheet of x-rays is employed and the x-ray tube moves over the object so that all the central beam rays pass through the part being radiographed at the same angle. This method eliminates size distortion and is applied particularly in long-bone radiography. |
| HE6.2.6 | . . . radiographic image enhancement qh |
| HE6.2.6.2e | . . . . computed x-ray tomography qh |
| SN | A radiologic examination in which a thin, collineated x-ray beam rotates about the patient, with registration of photon exit doses on detectors and manipulation of the output by computer to produce a three-dimensional image of a tissue or organ. | |
| ST | CAT | |
| CAT scan | ||
| computer assisted tomography | ||
| computerized tomography | ||
| CT scan |
| HE6.2.8 | . . . electrokymography qh |
| SN | Recording, from changes in the x-ray silhouette, the movements of the heart and great vessels. |
| HE6.4e | . . radionuclide imaging qh |
| SN | Imaging produced by introducing radionuclides into the body and observing their distribution by detecting radiation or particles resulting from their decay. Gives both structural (shape of body structures) and functional (transportation of radionuclides, accumulation in certain type of tissues) information. | |
| ST | autoradiography | |
| radioisotope scan | ||
| scintiphotography | ||
| BT | +HD14e radioisotope diagnosis qh ah |
| HE6.4.2 | . . . xenon regional cerebral blood flow technique qh |
| SN | Measures blood flow at different locations in the brain by introducing xenon 133 and measuring gamma ray emissions. | |
| ST | RCDBF | |
| BT | +HG22.8 brain diagnosis qh ah |
| HE6.4.4e | . . . emission computed tomography qh |
| HE6.4.4.2e | . . . . single photon emission computed tomography qh |
| SN | Uses gamma ray cameras to detect gamma rays (photons) emitted from injected radionuclides that emit a single photon with each nuclear decay. | |
| ST | SPECT |
| HE6.4.4.4e | . . . . positron emission tomography qh |
| SN | A technique that detects signals generated by the collision of positrons (positively charged particles) with electrons. Positrons are emitted by certain radioisotopes introduced into the body. The signals are used to generate an image of local metabolic and physiologic functions in tissues, such as glucose metabolism or blood flow in the brain. | |
| ST | PET | |
| RT | +HG22.4e neuroimaging qh ah |
| HE6.6e | . . magnetic imaging technique qh |
| HE6.6.2e | . . . magnetic resonance imaging qh |
| ST | MRI | |
| nuclear magnetic resonance imaging | ||
| RT | +HG22.4e neuroimaging qh ah |
| HE6.6.4e | . . . magnetic resonance spectroscopy qh |
| SN | A refined version of magnetic resonance imaging which visualizes the location of various molecules, including alcohol, in the brain. |
| HE6.8e | . . ultrasonography qh |
| ST | echography | |
| sonography | ||
| ultrasound scanning | ||
| NT | HG6.8.12e echocardiography qh ah |
| HE6.8.2 | . . . Doppler ultrasonography qh |
| HE6.10 | . . thermography qh |
| SN | The examination or recording of an image of the variations in surface temperatures of an object by detecting the infrared radiation emitted by the object. |
| HE8e | . electrodiagnosis qh |
| SN | The diagnosis of disease or dysfunction of the central and peripheral nervous systems and voluntary muscles by any method using electrical stimulation or recording electric activity. | |
| ST | electrophysiology (study method) | |
| NT | +HG6.8.14e electrocardiography qh ah | |
| HG20.2.16 electroretinography qh ah | ||
| HG20.2.18.2 electronystagmography qh ah | ||
| HG20.2.18.4 electrooculography qh ah | ||
| +HG22.8.4.2e electroencephalography qh ah | ||
| RT | +EG8e cell electrophysiology qh ah | |
| +HG22.8.6e evoked potential qh ah |
| HE8.2e | . . electromyography qh |
| HN | Introduced 1995. | |
| SN | A method of recording the currents generated in an active muscle. |
| HE10 | . plethysmography qh |
| SN | A technique for recording changes in the volume of an organ or body part by a plethysmograph. | |
| RT | +HG6 cardiovascular diagnosis qh ah | |
| +HG8.8e pulmonary function test qh ah |
| HFe | laboratory test d-out qh |
| BT | +HCe medical screening and diagnostic method qh ah | |
| RT | RP6e laboratory measurement qh ah |
| HF2e | . urinalysis qh |
| ST | urine analysis | |
| RT | +HB2e screening and diagnostic method for AOD use qh ah | |
| +JG26.2.4.2e identification and screening for AOD use qh ah | ||
| MO6.8.2e evidentiary proof of AODU qh ah | ||
| XB2.10.4e urine qh ah | ||
| +ZH2.12.2e glucose qh ah | ||
| ZM6e urea qh ah | ||
| +ZO6e proteins qh ah | ||
| ZT4.14.4e creatinine qh ah |
| HF4 | . breath analysis qh |
| ST | breath test | |
| NT | +OB6e breath analyzer qh ah | |
| RT | +HB2e screening and diagnostic method for AOD use qh ah | |
| +JG26.2.4.2e identification and screening for AOD use qh ah | ||
| MO6.8.2e evidentiary proof of AODU qh ah |
| HF4.2e | . . breath alcohol analysis qh |
| ST | BrAC | |
| breath alcohol concentration |
| HF6e | . saliva analysis qh |
| RT | +HB2e screening and diagnostic method for AOD use qh ah | |
| MO6.8.2e evidentiary proof of AODU qh ah |
| HF8e | . sweat analysis qh |
| RT | +HB2e screening and diagnostic method for AOD use qh ah |
| HF10e | . hair analysis qh |
| RT | +HB2e screening and diagnostic method for AOD use qh ah | |
| MO6.8.2e evidentiary proof of AODU qh ah | ||
| XH6.10 hair qh ah |
| HF12e | . tears analysis qh |
| RT | +HB2e screening and diagnostic method for AOD use qh ah |
| HF14e | . histological diagnosis qh |
| ST | cytodiagnosis | |
| cytologic test | ||
| exfoliative cytodiagnosis |
| HF16e | . hematologic test qh |
| ST | blood test | |
| BT | +XSe blood qh ah | |
| RT | +ET2e blood function qh ah | |
| +GT2e blood disorder qh ah |
| HF16.2 | . . blood grouping and crossmatching qh |
| ST | blood typing | |
| BT | +HF20.16 histocompatibility testing qh ah |
| HF16.4e | . . blood cell count qh |
| NT | HF16.6.6e erythrocyte count qh ah | |
| HF16.8.2e platelet count qh ah | ||
| RT | +XS2e blood cells qh ah |
| HF16.4.2e | . . . leukocyte count qh |
| ST | white blood cell count | |
| RT | +XS2.10e leukocytes qh ah |
| HF16.6 | . . erythrocyte parameter qh |
| ST | erythrocyte index | |
| RT | XS2.6e erythrocytes qh ah | |
| +YB12.6e folic acid qh ah | ||
| +YB12.24e vitamin B12 qh ah | ||
| +ZO6.4.10.2e hemoglobin qh ah | ||
| ZO6.8.12.6e erythropoietin qh ah |
| HF16.6.6e | . . . erythrocyte count qh |
| ST | RBC | |
| red blood cell count | ||
| BT | +HF16.4e blood cell count qh ah |
| HF16.6.8e | . . . mean corpuscular volume qh |
| ST | MCV | |
| BT | +HB4.6.2e AODR biological markers qh ah | |
| +HB4.6.2.8 alcohol-related biological markers qh ah | ||
| RT | AD14.6 long-term AOD use qh ah | |
| HG12.8e liver function test qh ah |
| HF16.6.10e | . . . hematocrit qh |
| ST | HCT |
| HF16.8 | . . platelet parameter qh |
| NT | ET2.4.4 clot retraction qh ah | |
| RT | XS6e platelets qh ah |
| HF16.8.2e | . . . platelet count qh |
| BT | +HF16.4e blood cell count qh ah |
| HF16.8.4e | . . . platelet function test qh |
| HF16.10 | . . blood coagulation test qh |
| RT | +ET2.4e blood coagulation qh ah | |
| HG12.8e liver function test qh ah |
| HF16.12 | . . blood sedimentation qh |
| RT | +GH16e communicable disease qh ah | |
| ZO6.4.10.6.4.16e fibrinogen qh ah |
| HF18e | . blood chemistry qh |
| ST | blood chemical analysis | |
| NT | +HB2.8e BAC qh ah | |
| BT | +XSe blood qh ah | |
| RT | EA6 body chemistry qh ah | |
| +ET2e blood function qh ah | ||
| +GT2e blood disorder qh ah | ||
| +HG6.8e heart function test qh ah | ||
| +HG12 digestive system diagnosis qh ah | ||
| XS8e plasma qh ah | ||
| XS10e serum qh ah |
| HF18.2 | . . cholesterol level qh |
| RT | GR6.12e hypercholesterolemia qh ah |
| HF18.4 | . . blood gas analysis qh |
| RT | +HG6 cardiovascular diagnosis qh ah | |
| +HG8.8e pulmonary function test qh ah |
| HF18.10e | . . blood urea nitrogen qh |
| HN | ETOH descriptor 2000. | |
| ST | BUN | |
| RT | +HG14.6e kidney function test qh ah |
| HF20e | . immunologic test qh |
| BT | +XTe immune system qh ah | |
| RT | +ET4e immune function qh ah | |
| +GUe immune disorder qh ah | ||
| HG16.10e pregnancy test qh ah |
| HF20.12 | . . immunologic cytotoxicity test qh |
| RT | +EE14.4.4.4.2.6e drug toxicity potential qh ah | |
| +XT4.2.8e cytotoxic cell qh ah |
| HF20.14e | . . fluorescent antibody technique qh |
| HF20.14.2 | . . . fluoroimmunoassay qh |
| HF20.16 | . . histocompatibility testing qh |
| NT | HF16.2 blood grouping and crossmatching qh ah |
| HF20.18e | . . immunoassay qh |
| HF20.18.2e | . . . immunoblotting qh |
| RT | CQ12.22.6.18e Western blotting qh ah |
| HF20.18.4 | . . . immunoenzyme technique qh |
| HF20.18.6 | . . . immunosorbent technique qh |
| HF20.18.8e | . . . radioimmunoassay qh |
| ST | RIA | |
| RT | +HD14e radioisotope diagnosis qh ah |
| HF20.20e | . . serologic test qh |
| SN | Tests of serum or plasma for antibodies or for presence of antigens characteristic of the disease in question. Used for the diagnosis of infectious disease. | |
| ST | diagnostic serology | |
| serologic diagnosis | ||
| serum diagnosis | ||
| RT | +GH16e communicable disease qh ah |
| HF20.20.6 | . . . complement fixation test qh |
| RT | YE8 complement (serum protein) qh ah |
| HF20.22 | . . skin test qh |
| SN | Any test in which an antigen is applied to the skin to observe the response of the patient. Used to determine immunity to infectious diseases, to identify allergens producing allergic reactions, and to assess ability to mount a cellular immune response. | |
| RT | +EF4.8 skin administration qh ah |
| HF22e | . enzyme test qh |
| HF24e | . genetic screening method qh |
| SN | Any process used to identify individuals within a population as having a specific genotype. It may be either implicit, as in screening for disease phenotypes known to be inherited, such as Mendelian traits, or explicit, as in screening nucleotide sequences in the genome. | |
| ST | genetic test | |
| NT | +HF26.4e genetic markers qh ah | |
| RT | +HG2e prenatal diagnosis qh ah |
| HF26e | . biological markers qh |
| SN | Use this term when biological markers and/or their use in diagnosis are discussed.
A biological marker is a biological compound or attribute that provides evidence of the presence of, or the vulnerability to, a specific disorder. In general, two types of markers are distinguished: state markers and trait markers. A state marker identifies a current abnormality that most typically reflects a transient or reactive condition of the subject, such as the degree of activity of an underlying disorder or the recent use of a drug. A trait marker identifies a relatively stable and enduring attribute that reflects a continuing condition or, particularly in the case of a genetic marker, a predisposition to a specific disorder. Most biological markers for alcohol and other drugs are state markers, and many simply reflect recent consumption history. Many, but not all, state markers for alcohol are in fact tests of hepatic damage (such as elevated plasma GGT). They are diagnostic tests of alterations in liver status that are secondary to chronic drinking and not valid indicators of alcohol dependence (WHO lexicon). | |
| ST | biomarkers | |
| NT | +HB4.6.2e AODR biological markers qh ah | |
| BT | +JA6.12.6 biological risk and protective factors qh ah | |
| RT | +GA10.8.2e disease susceptibility qh ah | |
| +HA screening and diagnostic method qh ah | ||
| +YZ12 molecular probes qh ah |
| HF26.2 | . . biochemical markers qh |
| HN | Introduced 2000. | |
| ST | chemical substances as biological markers | |
| NT | YC10.4e adenylyl cyclase qh ah | |
| YC14.8.2e monoamine oxidase qh ah | ||
| BT | +YMe other biological factors qh ah |
| HF26.2.2 | . . . differentiation antigens qh |
| HF26.2.4 | . . . biological tumor markers qh |
| HF26.4e | . . genetic markers qh |
| SN | Inherited characteristics, such as differences in DNA segments or in protein molecules, which occur with a disease such as alcoholism more frequently than chance would indicate. A marker that is known to occupy a particular place on a chromosome can be a gene or may be derived from a region of the genome that does not produce a functional product. If a marker gene is located on the chromosome and in proximity to the gene or genes responsible for a particular disease, then the marker and the disease genes are considered to be linked. | |
| NT | +HB4.6.2.4e AODR genetic markers qh ah | |
| BT | +HF24e genetic screening method qh ah | |
| RT | AJ4.8e genetic theory of AODU qh ah | |
| +EY2 Mendelian inheritance qh ah | ||
| +GA10.2.2 biological disease cause qh ah |
| HF26.6 | . . clinical markers qh |
| HN | Introduced 2000. | |
| ST | clinical characteristics as biological markers | |
| NT | HB4.6.2.6 AODR clinical markers qh ah |
| HF28 | . behavioral markers qh |
| HN | Introduced 2000. | |
| NT | HB4.6.4e AODR behavioral markers qh ah |
| HF30 | . sociocultural markers qh |
| HN | Introduced 2000. | |
| NT | HB4.6.6e AODR sociocultural markers qh ah |
| HG | system-specific diagnostic method d-out qh |
| SN | If complete specificity is necessary, index the diagnostic technique and the specific body part, system, or organ involved. | |
| BT | +HCe medical screening and diagnostic method qh ah | |
| RT | +Xe body part qh ah | |
| +XF body system or organ qh ah |
| HG2e | . prenatal diagnosis qh |
| RT | +HF24e genetic screening method qh ah | |
| +HG16e reproductive system diagnosis qh ah |
| HG2.2 | . . placental function test qh |
| HG2.4e | . . amniocentesis qh |
| BT | +HV6.14.2e paracentesis qh ah |
| HG2.6 | . . amnioscopy qh |
| BT | +HE4e endoscopy qh ah |
| HG2.8 | . . chorionic villi sampling qh |
| HG2.10 | . . fetoscopy qh |
| BT | +HE4e endoscopy qh ah |
| HG2.12e | . . fetal monitoring qh |
| RT | HD6e patient monitoring qh ah | |
| +HG16e reproductive system diagnosis qh ah |
| HG2.12.2 | . . . cardiotocography qh |
| RT | +HG6.8e heart function test qh ah |
| HG4 | . musculoskeletal diagnosis qh |
| HN | Introduced 2000. | |
| NT | HE2.2e computer-based morphometric analysis qh ah | |
| BT | +XGe musculoskeletal system qh ah |
| HG6 | . cardiovascular diagnosis qh |
| BT | +XJe cardiovascular system qh ah | |
| RT | +ELe cardiovascular system function qh ah | |
| +GNe cardiovascular disorder qh ah | ||
| GN8.4.6.2 bradycardia qh ah | ||
| GN8.4.6.4e tachycardia qh ah | ||
| +HD2 physical examination qh ah | ||
| +HE6.2e radiography qh ah | ||
| HE10 plethysmography qh ah | ||
| HF18.4 blood gas analysis qh ah | ||
| +HP4 catheterization qh ah |
| HG6.2 | . . blood pressure determination qh |
| RT | EL4.8e blood pressure qh ah |
| HG6.4 | . . blood volume determination qh |
| HG6.6e | . . blood flow measurement qh |
| ST | blood circulation time | |
| blood flow velocity | ||
| RT | +EL2e blood circulation qh ah | |
| HG22.8.8e cerebral blood flow qh ah |
| HG6.8e | . . heart function test qh |
| ST | functional cardiac measurement | |
| RT | +EL4e heart function qh ah | |
| +HF18e blood chemistry qh ah | ||
| HG2.12.2 cardiotocography qh ah |
| HG6.8.10 | . . . cardiac output qh |
| HG6.8.10.2 | . . . . stroke volume qh |
| HG6.8.12e | . . . echocardiography qh |
| HN | ETOH descriptor 1995. | |
| BT | +HE6.8e ultrasonography qh ah |
| HG6.8.14e | . . . electrocardiography qh |